[The treatment of lymphogranulomatosis].
D000328:Adult; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced; D008111:Liver Function Tests; D008297:Male; D008357:Mannomustine / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use
D003520:Cyclophosphamide; D008357:Mannomustine; D014228:Triaziquone; D011241:Prednisone
Zur Behandlung der Lymphogranulomatose.